Shane Tillakeratne
Overview
Explore the profile of Shane Tillakeratne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marshall A, Conway A, Cunningham E, Valerio H, Silk D, Alavi M, et al.
Viruses
. 2024 Nov;
16(11).
PMID: 39599877
The primary aim of this study was to establish the feasibility of implementing a larger RCT designed to evaluate the effect of financial incentives on HCV treatment initiation among persons...
2.
Tillakeratne S, Pearson S, Alavi M, Hajarizadeh B, Martinello M, Law M, et al.
Lancet Reg Health West Pac
. 2024 Sep;
51:101185.
PMID: 39282135
Background: Monitoring hepatitis B virus (HBV) and hepatitis C virus (HCV) liver-related morbidity and mortality is key to evaluate progress towards elimination targets. Methods: HBV and HCV notifications in NSW,...
3.
Valerio H, Alavi M, Marshall A, Hajarizadeh B, Amin J, Law M, et al.
Drug Alcohol Rev
. 2023 May;
43(5):1080-1092.
PMID: 37254644
Introduction: Females of childbearing age with hepatitis C virus (HCV) face increased marginalisation with intersecting, sex-specific barriers to direct acting antiviral (DAA) therapy. We assessed the factors associated with uptake...
4.
Grebely J, Gilliver R, McNaughton T, Conway A, Cunningham E, Henderson C, et al.
Int J Drug Policy
. 2023 Mar;
114:103982.
PMID: 36863287
Background: Point-of-care hepatitis C virus (HCV) RNA testing can facilitate single-visit diagnosis and treatment. This study evaluated a single-visit test and treat intervention integrating point-of-care HCV RNA testing, linkage to...
5.
Nyein P, Tillakeratne S, Phyu S, Yee M, Lwin M, Htike K, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851736
To evaluate a decentralised testing model and simplified treatment protocol of hepatitis C virus (HCV) infection to facilitate treatment scale-up in Myanmar, this prospective, observational study recruited HIV-HCV co-infected outpatients...
6.
Conway A, Read P, Gilliver R, McNaughton T, Valerio H, Cunningham E, et al.
Viruses
. 2022 Nov;
14(11).
PMID: 36366561
Background: New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by people...
7.
Hosseini-Hooshyar S, Alavi M, Martinello M, Valerio H, Tillakeratne S, Matthews G, et al.
J Viral Hepat
. 2022 Feb;
29(4):271-279.
PMID: 35175671
People living with HIV (PLHIV) are a priority population to receive hepatitis C virus (HCV) screening and treatment. We aimed to characterize the HCV care cascade among PLHIV between 2010...
8.
Valerio H, Alavi M, Law M, McManus H, Tillakeratne S, Bajis S, et al.
Clin Infect Dis
. 2021 Jun;
73(11):2037-2044.
PMID: 34107022
Background: People who inject drugs are at greater risk of hepatitis C virus (HCV) infection and hospitalization, yet admissions are not utilized for HCV treatment initiation. We aimed to assess...
9.
Valerio H, Alavi M, Law M, Tillakeratne S, Amin J, Janjua N, et al.
J Hepatol
. 2020 Sep;
74(2):293-302.
PMID: 32931879
Background & Aims: High HCV treatment uptake among people at most risk of transmission is essential to achieve elimination. We aimed to characterise subpopulations of people with HCV based on...
10.
Grebely J, Catlett B, Jayasinghe I, Valerio H, Hajarizadeh B, Verich A, et al.
J Infect Dis
. 2020 Jan;
221(12):2043-2049.
PMID: 31993636
Background: Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods: This study evaluated...